|
Market Closed -
London S.E.
11:35:01 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 1,606.00 GBX | -0.31% |
|
+3.15% | +3.61% |
| 09-08 | Hikma Pharmaceuticals Submits Epinephrine Nasal Spray for Regulatory Review in US, Europe, UK, and Canada | CI |
| 09-08 | Barclays Upgrades Hikma Pharmaceuticals to Equalweight, Boosts PT | MT |
Chart: Technical Analysis
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| HIK | Delayed | |
CBOE
| HIK | Real-time | |
|
OTC Markets
| HKMPF | Delayed | |
|
Tradegate
| H5P | Real-time | |
|
Boerse Muenchen
| H5P | Real-time | |
|
Deutsche Boerse AG
| H5P | Delayed | |
|
Börse Stuttgart
| H5P | Delayed | |
OTC Markets
| HKMPY | Delayed | |
|
Deutsche Boerse AG
| H5PA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 1,658 | 1,699 | 1,839 |
| Spread/Res. | -3.14% | -5.47% | -12.67% |
| Spread/Supp. | +7.21% | +10.68% | +32.84% |
| Support | 1,498 | 1,451 | 1,209 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- HIK Stock
- Charts Hikma Pharmaceuticals PLC
Select your edition
All financial news and data tailored to specific country editions
